Finance

Lists
HQ1:FRA
Oruka Therapeutics Inc
€79.50
+0.63%
(+0.50) 1D
Sep 8, 8:02:49 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HQ1...
Open
€79.50
High
€79.50
Low
€79.50
Mkt. cap
6.21B
Avg. vol.
3.00
Volume
0.00
52-wk high
€97.00
52-wk low
€12.70
No. of employees
68
Open
€79.50
High
€79.50
Low
€79.50
Mkt. cap
6.21B
Avg. vol.
3.00
Volume
0.00
52-wk high
€97.00
52-wk low
€12.70
No. of employees
68
About Oruka Therapeutics Inc
CEO-
Employees68
Founded2024
HeadquartersWestminster, Colorado, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
28.99M
27.64M
29.14M
43.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.12M
6.79M
7.29M
6.85M
Operating expense
34.10M
34.43M
36.43M
50.11M
Total operating expenses
34.10M
34.43M
36.43M
50.11M
Operating income
-34.10M
-34.43M
-36.43M
-50.11M
Other non operating income
-4.00K
-1.00K
8.00K
4.00K
EBT including unusual items
-30.28M
-29.58M
-31.82M
-41.21M
EBT excluding unusual items
-30.28M
-29.58M
-31.82M
-41.21M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-30.28M
-29.58M
-31.82M
-41.21M
Net profit margin
-
-
-
-
Earnings per share
-0.55
-0.45
-0.48
-0.55
Interest and investment income
3.83M
4.85M
4.61M
8.90M
Interest expense
-
-
-
-
Net interest expenses
3.83M
4.85M
4.61M
8.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
-34.08M
-34.40M
-36.39M
-50.06M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps